Almeda Ventures L.P. logo

Almeda Ventures L.P. (AMDA)

Market Closed
14 Oct, 03:25 PM
TASE TASE
244. 00
ILA
0
0%
ILA
22.7M Market Cap
- P/E Ratio
- Div Yield
122 Volume
0 Eps
244 ILA
Previous Close
Add Transaction
Day Range
244 244
Year Range
2.49 307
Want to track AMDA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

AMDA closed yesterday higher at 244 ILA, an increase of 0% from Tuesday's close, completing a monthly decrease of -2.126% or -5.3 ILA. Over the past 12 months, AMDA stock gained 30.6909%.
AMDA pays dividends to its shareholders, with the most recent payment made on Sep 03, 2026. The next estimated payment will be in In 1 month on Dec 03, 2026 for a total of 30.4191 ILA.
The last earnings report, released on Sep 18, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

AMDA Chart

People also search for

Identi Healthcare Ltd.
168.4 ILA
+0.2381%
Big Tech 50 Research and Development L.P.
113 ILA
0%
Feat Fund Investment L.P.
139.5 ILA
0%
Gibui Holdings Ltd.
2.1 ILA
0%
ERECH FINANCE
145.8 ILA
-5.3247%

Almeda Ventures L.P. (AMDA) FAQ

What is the stock price today?

The current price is 244.00 ILA.

On which exchange is it traded?

Almeda Ventures L.P. is listed on TASE.

What is its stock symbol?

The ticker symbol is AMDA.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 22.7M.

Has Almeda Ventures L.P. ever had a stock split?

No, there has never been a stock split.

Almeda Ventures L.P. Profile

Insurance Industry
Financials Sector
Dr. Irit Yaniv M.D. CEO
TASE Exchange
IL0011689622 ISIN
Il Country
- Employees
26 Aug 2026 Last Dividend
- Last Split
- IPO Date

Overview

Almeda Ventures Limited Partnership is a trailblazing venture capital firm, established in 2020 and headquartered in Tel Aviv, Israel. Carving out a niche in the investment landscape, Almeda Ventures is dedicated to nurturing innovative companies at the seed, startup, early venture, and middle market stages. The firm is distinguished by its strategic focus on health technology, leveraging public R&D partnerships, and prioritizing investments that promise to revolutionize the medical and life sciences fields. Its geographical scope spans Israel, the USA, and Europe, aiming to foster a global impact through cutting-edge technological advancements.

Products and Services

  • Public R&D Partnership Investments:
  • Almeda Ventures identifies and invests in promising health technology initiatives that benefit from public research and development partnerships. This approach enables the firm to support technologies that have access to public funding, resources, and expertise, enhancing their likelihood for success and innovation.

  • Medical Devices:
  • Investing in the development and commercialization of medical devices is a core focus area for Almeda Ventures. The firm scouts for cutting-edge medical devices that promise to improve patient care, with a keen interest in innovations that offer novel solutions to existing health challenges.

  • Digital Health:
  • The firm is proactive in seeking out digital health solutions that leverage technology to enhance healthcare delivery. This encompasses a wide range of technologies, including telehealth, health information technologies, and wearable devices, all aimed at improving healthcare outcomes and efficiency.

  • Bio-Convergence:
  • Almeda Ventures places a significant emphasis on bio-convergence, an innovative field at the intersection of biology with engineering, computational science, and other disciplines. The firm invests in companies that are pioneering this cross-disciplinary approach to address complex health challenges.

  • Life Sciences Research and Development:
  • Supporting life sciences research and development is another pillar of Almeda Ventures' investment strategy. The firm backs companies engaged in groundbreaking R&D with the potential to yield transformative discoveries and therapeutic solutions in health and medicine.

Contact Information

Address: Azrieli Center, Tel Aviv, Israel, 67023